Actively Recruiting
Risk Factors for AKI in Patients Undergoing VATS for Pulmonary Resection
Led by Atatürk Chest Diseases and Chest Surgery Training and Research Hospital · Updated on 2025-01-30
100
Participants Needed
1
Research Sites
87 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to investigate the potential factors contributing to the development of Acute Kidney Injury (AKI) in patients undergoing pulmonary resection with Video Assisted Thoracoscopic Surgery (VATS) for lung malignancy. The study will focus on demographic data, laboratory parameters, perioperative fluid management, and haemodynamics. The research will be conducted at SBÜ Ankara Atatürk Sanatorium Training and Research Hospital. The study will involve patients who have given informed consent and will undergo VATS with standard anaesthesia monitoring. Anaesthesia management will follow our routine protocol in our clinic. Patients will be divided into two groups based on whether they have a more than 25% decrease in estimated glomerular filtration rate (t-GFH) and/or a 1.5-fold increase in serum creatinine and/or a 6-hour urine volume of less than 0.5 ml/kg/h. The patients will be divided into two groups based on this definition, and the risk factors between these groups will be analysed. The preoperative routine blood values, demographic data (age, gender, height, weight, and BMI), ASA physical status, smoking and alcohol habits, comorbidities, and regular medication use will be recorded. Intraoperative urine output and haemodynamic parameters will also be monitored. Routine blood gas analysis, blood urea nitrogen (BUN), glomerular filtration rate (GFR), albumin, haemoglobin, sodium, potassium, chlorine, and magnesium will be measured and recorded, along with urine output and t-GFH. Patients will be evaluated in the hospital on the day the surgeon calls for a postoperative check-up and on the 30th postoperative day to see if there are any complications.
CONDITIONS
Official Title
Risk Factors for AKI in Patients Undergoing VATS for Pulmonary Resection
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Between 18 and 65 years of age
- American Society of Anesthesiologists (ASA) physical status 1 to 3
- Undergoing elective wedge resection, segmentectomy, or lobectomy with VATS for lung malignancy
You will not qualify if you...
- Body mass index (BMI) less than 18.5 kg/m2 or greater than 35 kg/m2
- Impaired renal function with serum creatinine above 1.3 mg/dL for men or 1.1 mg/dL for women
- Received radiocontrast material before surgery
- Diagnosed and treated for congestive heart failure
- History of pulmonary edema
- Long-term use (over 30 days) of steroids or non-steroidal anti-inflammatory drugs
- Intubated in intensive care unit
- Requires massive blood transfusion during surgery
- Missing data for required study parameters
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ankara Atatürk Sanatorium Training and Research Hospital
Ankara, Keçiören, Turkey (Türkiye), 06290
Actively Recruiting
Research Team
A
Ali ALAGÖZ, professor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here